China’s Bluepha announced on Monday the completion of an extended round that brought the overall fundraising scale in its Series B round to 1.5 billion yuan ($235.3 million), as the startup continues to bring eco-friendly synthetic biology solutions to various sectors.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
